NR

Nagasekhar Ramineni

Active Director Managing Director DIN 08400770
DIN 08400770 First appointment Mar 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Nagasekhar Ramineni

Data last updated:

Nagasekhar Ramineni is a Managing Director at Averx Drugs Private Limited (since 2019). The company operates in Pharma. Averx Drugs Private Limited reported revenue of ₹6.36 Cr (FY 2021).

DIN 08400770
Primary Designation Managing Director
Industry Pharma
First Appointment 27 Mar 2019
Oldest Company Age 12 yrs
Largest company Averx Drugs Private Limited · ₹6.36 Cr (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Averx Drugs Private Limited U24100AP2014PTC095163
Managing Director27 Mar 20192014₹6.36 Cr (FY 2021)Active

Board colleagues of Nagasekhar Ramineni

Directorship timeline

Open interactive timeline →
Averx Drugs Private Limited
Premium access

Shareholding and investment profile for Nagasekhar Ramineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nagasekhar Ramineni

Nagasekhar Ramineni currently holds 1 directorship: Averx Drugs Private Limited (Managing Director, since 27 Mar 2019, revenue ₹6.36 Cr (FY 2021)).

Nagasekhar Ramineni was first appointed on 27 Mar 2019 as Managing Director at Averx Drugs Private Limited.

The current boards of Nagasekhar Ramineni's companies include Dhana Lakshmi Tirupathi (Averx Drugs Private Limited), Srinivas Ramineni (Averx Drugs Private Limited), Vns Gopal Raju Kurapati (Averx Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available